Table 2.
Physicians’ Prescription Patterns and Major Influential Factors
| Variable | Apologist Group | Eliminitavist Group | |||
|---|---|---|---|---|---|
| n | % | n | % | p-value | |
| Which of the following category of patients have you prescribed BiDil to over the past 5 years? | |||||
| Black or African American | 19 | 100.0 | 23 | 85.2 | |
| Black Hispanic | 0 | 0.0 | 1 | 3.7 | |
| White European American | 0 | 0.0 | 3 | 11.1 | 0.25 |
| What factor most influenced your decision to prescribe BiDil? | |||||
| Inefficacy of standard therapies | 6 | 27.3 | 11 | 39.3 | |
| Self-identified race | 9 | 40.9 | 5 | 17.8 | |
| Severity of disease | 4 | 18.2 | 8 | 28.6 | |
| Other | 3 | 13.6 | 4 | 14.3 | 0.36 |
| Which factor do you believe best explains the differential efficacy of BiDil? | |||||
| Environmental | 1 | 4.6 | 0 | 0.0 | |
| Pharmacogenomic | 7 | 31.8 | 6 | 22.2 | |
| Physiological | 3 | 13.6 | 8 | 29.6 | |
| Unknown | 11 | 50.0 | 13 | 48.2 | 0.37 |